Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Protein kinase C delta enhances proliferation and survival of murine mammary cells.
Grossoni VC, Falbo KB, Kazanietz MG, de Kier Joffé ED, Urtreger AJ. Grossoni VC, et al. Among authors: urtreger aj. Mol Carcinog. 2007 May;46(5):381-90. doi: 10.1002/mc.20287. Mol Carcinog. 2007. PMID: 17219421
Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma.
Alonso DF, Farías EF, Urtreger A, Ladeda V, Vidal MC, Bal De Kier Joffé E. Alonso DF, et al. Among authors: urtreger a. J Surg Oncol. 1996 Aug;62(4):288-97. doi: 10.1002/(SICI)1096-9098(199608)62:4<288::AID-JSO14>3.0.CO;2-1. J Surg Oncol. 1996. PMID: 8691844
Expression of RGD minus fibronectin that does not form extracellular matrix fibrils is sufficient to decrease tumor metastasis.
Urtreger A, Porro F, Puricelli L, Werbajh S, Baralle FE, Bal de Kier Joffé E, Kornblihtt AR, Muro AF. Urtreger A, et al. Int J Cancer. 1998 Oct 5;78(2):233-41. doi: 10.1002/(sici)1097-0215(19981005)78:2<233::aid-ijc18>3.0.co;2-b. Int J Cancer. 1998. PMID: 9754657
Involvement of fibronectin in the regulation of urokinase production and binding in murine mammary tumor cells.
Urtreger AJ, Aguirre Ghiso JA, Werbajh SE, Puricelli LI, Muro AF, Bal de Kier Joff E. Urtreger AJ, et al. Int J Cancer. 1999 Aug 27;82(5):748-53. doi: 10.1002/(sici)1097-0215(19990827)82:5<748::aid-ijc20>3.0.co;2-r. Int J Cancer. 1999. PMID: 10417775
New murine cell line derived from a spontaneous lung tumor induces paraneoplastic syndromes.
Urtreger AJ, Diament MJ, Ranuncolo SM, Del C Vidal M, Puricelli LI, Klein SM, De Kier Joffe ED. Urtreger AJ, et al. Int J Oncol. 2001 Mar;18(3):639-47. doi: 10.3892/ijo.18.3.639. Int J Oncol. 2001. PMID: 11179499
Involvement of TGF-beta(s)/T(beta)Rs system in tumor progression of murine mammary adenocarcinomas.
Daroqui MC, Puricelli LI, Urtreger AJ, Elizalde PV, Lanuza GM, Bal de Kier Joffé E. Daroqui MC, et al. Among authors: urtreger aj. Breast Cancer Res Treat. 2003 Aug;80(3):287-301. doi: 10.1023/a:1024910332621. Breast Cancer Res Treat. 2003. PMID: 14503801
Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model.
Bumaschny V, Urtreger A, Diament M, Krasnapolski M, Fiszman G, Klein S, Joffé EB. Bumaschny V, et al. Among authors: urtreger a. Breast Cancer Res. 2004;6(2):R116-29. doi: 10.1186/bcr757. Epub 2004 Jan 15. Breast Cancer Res. 2004. PMID: 14979922 Free PMC article.
Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells.
Urtreger AJ, Grossoni VC, Falbo KB, Kazanietz MG, Bal de Kier Joffé ED. Urtreger AJ, et al. Mol Carcinog. 2005 Jan;42(1):29-39. doi: 10.1002/mc.20066. Mol Carcinog. 2005. PMID: 15546134
Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.
Urtreger AJ, Werbajh SE, Verrecchia F, Mauviel A, Puricelli LI, Kornblihtt AR, Bal de Kier Joffé ED. Urtreger AJ, et al. Oncol Rep. 2006 Dec;16(6):1403-10. Oncol Rep. 2006. PMID: 17089068
Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Carnevale RP, Proietti CJ, Salatino M, Urtreger A, Peluffo G, Edwards DP, Boonyaratanakornkit V, Charreau EH, Bal de Kier Joffé E, Schillaci R, Elizalde PV. Carnevale RP, et al. Among authors: urtreger a. Mol Endocrinol. 2007 Jun;21(6):1335-58. doi: 10.1210/me.2006-0304. Epub 2007 Apr 17. Mol Endocrinol. 2007. PMID: 17440047
29 results
Jump to page
Feedback